These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24011928)

  • 21. Visuospatial perception: an emerging biomarker for Alzheimer's disease.
    Mandal PK; Joshi J; Saharan S
    J Alzheimers Dis; 2012; 31 Suppl 3():S117-35. PubMed ID: 22810101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual exploration of facial emotion by healthy older adults and patients with Alzheimer disease.
    Ogrocki PK; Hills AC; Strauss ME
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Oct; 13(4):271-8. PubMed ID: 11186163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual perceptual organization deficits in Alzheimer's dementia.
    Uhlhaas PJ; Pantel J; Lanfermann H; Prvulovic D; Haenschel C; Maurer K; Linden DE
    Dement Geriatr Cogn Disord; 2008; 25(5):465-75. PubMed ID: 18408365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinal microvasculature in Alzheimer's disease.
    Cheung CY; Ong YT; Ikram MK; Chen C; Wong TY
    J Alzheimers Dis; 2014; 42 Suppl 4():S339-52. PubMed ID: 25351108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
    Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
    Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visuomotor impairment in early-stage Alzheimer's disease: changes in relative timing of eye and hand movements.
    Verheij S; Muilwijk D; Pel JJ; van der Cammen TJ; Mattace-Raso FU; van der Steen J
    J Alzheimers Dis; 2012; 30(1):131-43. PubMed ID: 22377783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical indications for analysis of Alzheimer's disease CSF biomarkers.
    Engelborghs S
    Rev Neurol (Paris); 2013 Oct; 169(10):709-14. PubMed ID: 24016466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dissociation of structural and functional parameters of the retina and optic nerve in a patient with Alzheimer's disease (clinical case)].
    Erichev VP; Panyushkina LA; Ronzina IA
    Vestn Oftalmol; 2015; 131(2):89-93. PubMed ID: 26080589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
    Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
    J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alzheimer's disease and geriatric eye diseases in the aspect of amyloid genesis].
    Ermilov VV; Tiurenkov IN; Nesterova AA; Zagrebin VA
    Arkh Patol; 2013; 75(2):37-42. PubMed ID: 24006764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unmet visual needs of Alzheimer's disease patients in long-term care facilities.
    Koch JM; Datta G; Makhdoom S; Grossberg GT
    J Am Med Dir Assoc; 2005; 6(4):233-7. PubMed ID: 16005408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
    van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
    Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of neuropsychological impairment in Alzheimer's disease and mixed dementia.
    Dong Y; Gan DZ; Tay SZ; Koay WI; Collinson SL; Hilal S; Venketasubramanian N; Chen C
    J Neurol Sci; 2013 Oct; 333(1-2):5-8. PubMed ID: 23978422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinergic modulation, visual function and Alzheimer's dementia.
    Nobili L; Sannita WG
    Vision Res; 1997 Dec; 37(24):3559-71. PubMed ID: 9425531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parallel findings in age-related macular degeneration and Alzheimer's disease.
    Ohno-Matsui K
    Prog Retin Eye Res; 2011 Jul; 30(4):217-38. PubMed ID: 21440663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glia-Mediated Retinal Neuroinflammation as a Biomarker in Alzheimer's Disease.
    Madeira MH; Ambrósio AF; Santiago AR
    Ophthalmic Res; 2015; 54(4):204-11. PubMed ID: 26517861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential Retinal Biomarkers in Alzheimer's Disease.
    García-Bermúdez MY; Vohra R; Freude K; Wijngaarden PV; Martin K; Thomsen MS; Aldana BI; Kolko M
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.